Ertugliflozin and Pneumonia - a phase IV clinical study of FDA data

Summary:

Pneumonia is reported as a side effect among people who take Ertugliflozin (ertugliflozin), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Metformin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Pneumonia when taking Ertugliflozin. It is created by eHealthMe based on reports of 116 people who have side effects when taking Ertugliflozin from the FDA, and is updated regularly.

What is Ertugliflozin?

Ertugliflozin has active ingredients of ertugliflozin. eHealthMe is studying from 116 Ertugliflozin users. Check the latest studies of Ertugliflozin.

What is Pneumonia?

Pneumonia is found to be associated with 3,353 drugs and 4,679 conditions by eHealthMe. Check the latest studies of Pneumonia.

On Aug, 11, 2026

116 people reported to have side effects when taking Ertugliflozin.
Among them, 12 people (10.34%) have Pneumonia.

Among these 12 people:

How long have people been on Ertugliflozin when they have Pneumonia? *

What is the gender of people who have Pneumonia when taking Ertugliflozin? *

female: 0.0 %
male: 100 %

What is the age of people who have Pneumonia when taking Ertugliflozin? *

What are other drugs people take besides Ertugliflozin? *

Metformin: 5 people, 41.67%
Zyprexa: 2 people, 16.67%
Zocor: 2 people, 16.67%
Metformin Hydrochloride: 2 people, 16.67%
Lisinopril: 2 people, 16.67%
Euthyrox: 2 people, 16.67%
Rosuvastatin Calcium: 1 person, 8.33%
Nevanac: 1 person, 8.33%
Famotidine: 1 person, 8.33%
Entresto: 1 person, 8.33%

What are other side effects people have besides Pneumonia? *

Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 7 people, 58.33%
Overdose: 2 people, 16.67%
High Blood Pressure: 2 people, 16.67%
High Blood Cholesterol: 2 people, 16.67%
Diabetes: 2 people, 16.67%
Consciousness - Decreased: 2 people, 16.67%
White Blood Cell Count Abnormal: 1 person, 8.33%
Thrombocytopenia (decrease of platelets in blood): 1 person, 8.33%
Tachypnea: 1 person, 8.33%
Sinusitis (inflammation of sinus): 1 person, 8.33%

What are the existing conditions these people have? *

Type 2 Diabetes: 9 people, 75.00%
High Blood Pressure: 8 people, 66.67%
Stable Angina (a constant chest pain): 5 people, 41.67%
Pruritus Genital (uneasy irritation of the skin of the vagina and the surrounding area): 5 people, 41.67%
Diabetes: 3 people, 25.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 16.67%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 16.67%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 8.33%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 1 person, 8.33%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ertugliflozin and have Pneumonia?

- Check whether Pneumonia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ertugliflozin:

Ertugliflozin (116 reports)

Pneumonia treatments and more:

Pneumonia (433,139 reports)

Browse all side effects of Ertugliflozin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pneumonia:

Pneumonia (3,353 drugs)

Browse all the conditions that are associated with Pneumonia:

Pneumonia (4,679 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ertugliflozin (the active ingredients of Ertugliflozin) and Ertugliflozin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.